Zoekresultaten - 15 results

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.

Verburgh, Vera; Jacques, Marjorie; Steven Van Gucht; Veronik Hutse Source: BMC Public Health, Volume 19, Issue 1 (2019) Abstract: BACKGROUND: Prevalence data of chronic hepatitis C virus (HCV) infection are ...

The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006: a comparative analysis with hepatitis A virus seroprevalence

as well as relying on mixture models applied to continuous pathogen-specific immunoglobulin G antibody titre concentrations. The age-specific seroprevalence of hepatitis A virus (HAV), based on three ...

Hepatitis E virus serology and PCR: does the methodology matter?

Colle, Isabelle; Veronik Hutse; Suin, Vanessa; Wautier, Magali; Steven Van Gucht; Van Vlierberghe, Hans; Padalko, Elizaveta Source: Arch Virol, Volume 162, Issue 9, p.2625-2632 (2017) Keywords: Antibodies ...

Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation.

(2014) Keywords: ADOLESCENT Belgium Child Child, Preschool Female Hepatitis B Hepatitis B Antibodies Hepatitis B Vaccines Hepatitis B virus Humans Immunization Schedule Infant Male Mass Vaccination ...

Validation of a new ELISA method for in vitro potency testing of hepatitis A vaccines

HealthCare (EDQM) Council of Europe, Volume December 2013, Number 92, Strasbourg, France, p.29 (2013) Keywords: 2012 a an antibodies Antibody AS batch release Comparison Control Correlation detection Europe ...

M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.

Virus-Like Particle Viral Load Abstract: The ectodomain of influenza A matrix protein 2 (M2 e) is a candidate for a universal influenza A vaccine. We used recombinant Hepatitis B core antigen to produce ...

Comparative hepatitis A seroepidemiology in 10 European countries

GROUPS Age-group Aged an antibodies Antibody Area article AS Belgium CHILDREN Common Countries CZECH Czech Republic disease electronic Europe European European countries Finland Germany Group health ...

Establishment of a biological reference preparation for Hepatitis A Vaccine (Inactivated, Non-adsorbed)4425

France, p.15- 29 (2010) Keywords: 2009 a Agreement ALL an antibodies Antibody AS at Cell cell culture culture d data detection Establish European healthcare Hepatitis Hepatitis A Hepatitis A Vaccines ...

A population-based prevalence study of hepatitis A, B and C virus using oral fluid in Flanders, Belgium.

Hepatitis A Hepatitis A Antibodies Hepatitis B Hepatitis B Surface Antigens Hepatitis C Hepatitis C Antibodies Humans Infant Infant, Newborn Male middle aged Population Surveillance prevalence Saliva ...

QR code

QR code for this page URL